Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy

American Journal of Neuroradiology

Volumn 17, Issue 4, 1996, Pages 737-747

  Shimizu, Hiroaki ^a,b   Kumabe, Toshihiro ^a   Tominaga, Teiji ^a   Kayama, Takamasa ^c   Hara, Kazushi ^a   Ono, Yasuki ^a   Sato, Koetsu ^b   Arai, Nobuyuki ^d   Fujiwara, Satoru ^b   Yoshimoto, Takashi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOHNAN HOSPITAL   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d GE HealthCare Japan   (Japan)

Author keywords

Brain neoplasms, magnetic resonance; Magnetic resonance, spectroscopy

Indexed keywords

ADULT; ARTICLE; BRAIN CANCER; BRAIN TUMOR; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN EXPERIMENT; MALE; MENINGIOMA; NORMAL HUMAN; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE IMAGING; REFERENCE VALUE; SPECTROSCOPY;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BRAIN NEOPLASMS; CHOLINE; CREATINE; ENERGY METABOLISM; FEMALE; GLIOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LACTATES; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENINGIOMA; MIDDLE AGED; PHANTOMS, IMAGING; PHOSPHOCREATINE; PROTONS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0345605294     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barker PB, Glickson JD, Bryan N. In vivo magnetic resonance spectroscopy of human brain tumors. Top Magn Reson Imaging 1993;5:32-45
2. Arnold DL, Shoubridge EA, Villemure JG, Feindel W. Proton and phosphorous magnetic resonance spectroscopy of human astrocytomas in vivo: Preliminary observations on tumor grading. NMR Biomed 1990;3:184-189
3. 1H MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172: 541-548
4. Langkowski JH, Wieland J, Bomsdorf H, et al. Preoperative localized in vivo proton spectroscopy in cerebral tumors at 4.0 Tesla: first results. Magn Reson Imaging 1989;7:547-555
5. Herholz K, Heindel W, Luyten PR, et al. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Ann Neurol 1992;31:319-327
6. 3H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76
7. Ott D, Hennig J, Ernst T: Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
8. 1H NMR spectroscopic imaging. Magn Reson Med 1990; 13:62-76
9. Hayes CE, Edelstein WA, Schenck JF, Mueller OM, Eash M. An efficient, highly homogeneous radiofrequency coil for whole-body NMR imaging at 1.5T. J Magn Reson 1985;63:622-628
10. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
11. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System, 2nd ed. Berlin, Germany: Springer-Verlag, 1993:11-30
12. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 1994;35:606-614
13. Webb PG, Sailasuta N, Kohler SJ, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med 1994;31:365-373
14. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19-27
15. Ross B, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992;14:128-140
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30: 672-679
17. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain, I: compartments and water. J Magn Reson 1993;102:1-8
18. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain, II: metabolite concentrations. J Magn Reson 1993;102:9-19
19. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992;184:123-130
20. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 1992; 31:202-211
21. 1H MR spectroscopic imaging and PET. Radiology 1990;176:791-799
22. Kugel H, Heindel W, Ernestus R-I, Bunke J, du Mensil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709
23. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
24. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30: 424-437
25. Ernst T, Hennig J, Ott D, Friedburg H. The importance of the voxel size in clinical 1H spectroscopy of the human brain. NMR Biomed 1989;2:216-224
26. Narayama PA, Fotedar LK, Jackson EF, Bohan TP, Butler U, Wolinsky JS. Regional in vivo proton magnetic resonance spectroscopy of brain. J Magn Reson 1989;83:44-52
27. Hennig J, Pfister H, Ernst T, Ott D. Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 1992;5:193-199